La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING

Identifieur interne : 002096 ( Main/Exploration ); précédent : 002095; suivant : 002097

IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING

Auteurs : D. Mongeon [Canada] ; P. Blanchet [Canada] ; J. Messier [Canada]

Source :

RBID : Pascal:09-0119781

Descripteurs français

English descriptors

Abstract

Increasing evidence suggests that the pathophysiology of movement disorders in Parkinson's disease (PD) includes deficits in sensory processing and integration. However, the exact nature of these deficits and the ability of dopamine medication to correct them have not been thoroughly examined in previous studies. For instance, it remains unclear whether PD patients have globally impaired sensorimotor integration functions or selective deficiencies in processing proprioception. We evaluated the specific deficits of PD patients in sensorimotor integration and proprioceptive processing by testing their ability to perform three-dimensional (3D) reaching movements in four conditions in which the sensory signals defining target and hand positions (visual and/or proprioceptive) varied. Ten healthy subjects and 11 PD patients, ON dopamine medication and in the OFF state, were tested. PD patients in the OFF state showed a greater mean level of 3D errors relative to controls when the only available sensory information about target and hand position came from proprioception, but this difference did not reach significance. This indicates that deficient proprioception is not an early key feature of PD. Interestingly, the inaccuracies of a number of PD subjects further increased in the ON medicated state relative to healthy controls when reaching to proprioceptively-defined targets, and this between group difference was statistically significant. However, dopamine medication did not consistently degrade the reaching accuracy of PD patients, with both negative and positive effects on accuracy of reaching to proprioceptive-defined targets. Together, these findings indicate that dopamine replacement therapy not only did not normalize sensorimotor performance to the level of controls, but also induced deficits in the processing of proprioceptive information in some of the PD patients tested. Furthermore, the diversity of effects of medication on accuracy of reaching to proprioceptively-defined targets supports the idea that dysfunction of dopaminergic circuits within the basal ganglia is not primarily responsible for the proprioceptive processing deficits of PD patients.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING</title>
<author>
<name sortKey="Mongeon, D" sort="Mongeon, D" uniqKey="Mongeon D" first="D." last="Mongeon">D. Mongeon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Département de Kinésiologie, Université de Montréal, 2100, boul. Édouard-Montpetit, bureau 8225</s1>
<s2>Montréal, Québec, QC H3T 1J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, QC H3T 1J4</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Institut universitaire de gériatrie de Montréal, Université de Montréal, 4545, Chemin Queen-Mary</s1>
<s2>Montréal, Québec, H3W 1W4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H3W 1W4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Blanchet, P" sort="Blanchet, P" uniqKey="Blanchet P" first="P." last="Blanchet">P. Blanchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Département de stomatologie, Université de Montréal, Pavillon Roger-Gaudry 2900, boul. Édouard-Montpetit</s1>
<s2>Montréal, Québec, H3T 1J4</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H3T 1J4</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Services de neurologie du Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Pavillon DesChamps, 1560, rue Sherbrooke est</s1>
<s2>Montréal, Québec, H2L 4M1</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H2L 4M1</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Messier, J" sort="Messier, J" uniqKey="Messier J" first="J." last="Messier">J. Messier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Département de Kinésiologie, Université de Montréal, 2100, boul. Édouard-Montpetit, bureau 8225</s1>
<s2>Montréal, Québec, QC H3T 1J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, QC H3T 1J4</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Institut universitaire de gériatrie de Montréal, Université de Montréal, 4545, Chemin Queen-Mary</s1>
<s2>Montréal, Québec, H3W 1W4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H3W 1W4</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">09-0119781</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0119781 INIST</idno>
<idno type="RBID">Pascal:09-0119781</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000569</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000723</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000460</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000460</idno>
<idno type="wicri:doubleKey">0306-4522:2009:Mongeon D:impact:of:parkinson</idno>
<idno type="wicri:Area/Main/Merge">002264</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18996173</idno>
<idno type="wicri:Area/PubMed/Corpus">000F04</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F04</idno>
<idno type="wicri:Area/PubMed/Curation">000F04</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F04</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F04</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F04</idno>
<idno type="wicri:Area/Ncbi/Merge">000981</idno>
<idno type="wicri:Area/Ncbi/Curation">000981</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000981</idno>
<idno type="wicri:doubleKey">0306-4522:2009:Mongeon D:impact:of:parkinson</idno>
<idno type="wicri:Area/Main/Merge">001F88</idno>
<idno type="wicri:Area/Main/Curation">002096</idno>
<idno type="wicri:Area/Main/Exploration">002096</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING</title>
<author>
<name sortKey="Mongeon, D" sort="Mongeon, D" uniqKey="Mongeon D" first="D." last="Mongeon">D. Mongeon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Département de Kinésiologie, Université de Montréal, 2100, boul. Édouard-Montpetit, bureau 8225</s1>
<s2>Montréal, Québec, QC H3T 1J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, QC H3T 1J4</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Institut universitaire de gériatrie de Montréal, Université de Montréal, 4545, Chemin Queen-Mary</s1>
<s2>Montréal, Québec, H3W 1W4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H3W 1W4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Blanchet, P" sort="Blanchet, P" uniqKey="Blanchet P" first="P." last="Blanchet">P. Blanchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Département de stomatologie, Université de Montréal, Pavillon Roger-Gaudry 2900, boul. Édouard-Montpetit</s1>
<s2>Montréal, Québec, H3T 1J4</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H3T 1J4</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Services de neurologie du Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Pavillon DesChamps, 1560, rue Sherbrooke est</s1>
<s2>Montréal, Québec, H2L 4M1</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H2L 4M1</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Messier, J" sort="Messier, J" uniqKey="Messier J" first="J." last="Messier">J. Messier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Département de Kinésiologie, Université de Montréal, 2100, boul. Édouard-Montpetit, bureau 8225</s1>
<s2>Montréal, Québec, QC H3T 1J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, QC H3T 1J4</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Institut universitaire de gériatrie de Montréal, Université de Montréal, 4545, Chemin Queen-Mary</s1>
<s2>Montréal, Québec, H3W 1W4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montréal, Québec, H3W 1W4</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Neuroscience</title>
<title level="j" type="abbreviated">Neuroscience</title>
<idno type="ISSN">0306-4522</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neuroscience</title>
<title level="j" type="abbreviated">Neuroscience</title>
<idno type="ISSN">0306-4522</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Basal ganglion</term>
<term>Biomechanical Phenomena</term>
<term>Dopamine</term>
<term>Dopamine Agents (pharmacology)</term>
<term>Dopamine Agents (therapeutic use)</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Memory (drug effects)</term>
<term>Memory (physiology)</term>
<term>Middle Aged</term>
<term>Movement (drug effects)</term>
<term>Movement (physiology)</term>
<term>Orientation (drug effects)</term>
<term>Orientation (physiology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson disease</term>
<term>Proprioception</term>
<term>Proprioception (drug effects)</term>
<term>Proprioception (physiology)</term>
<term>Psychomotor Performance (drug effects)</term>
<term>Psychomotor Performance (physiology)</term>
<term>Sensorimotor coordination</term>
<term>Space Perception (drug effects)</term>
<term>Space Perception (physiology)</term>
<term>Vision, Ocular (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Dopamine Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Dopamine Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Memory</term>
<term>Movement</term>
<term>Orientation</term>
<term>Proprioception</term>
<term>Psychomotor Performance</term>
<term>Space Perception</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Memory</term>
<term>Movement</term>
<term>Orientation</term>
<term>Proprioception</term>
<term>Psychomotor Performance</term>
<term>Space Perception</term>
<term>Vision, Ocular</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Biomechanical Phenomena</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Dopamine</term>
<term>Proprioception</term>
<term>Coordination sensorimotrice</term>
<term>Noyau gris central</term>
<term>Maladie de Parkinson</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Increasing evidence suggests that the pathophysiology of movement disorders in Parkinson's disease (PD) includes deficits in sensory processing and integration. However, the exact nature of these deficits and the ability of dopamine medication to correct them have not been thoroughly examined in previous studies. For instance, it remains unclear whether PD patients have globally impaired sensorimotor integration functions or selective deficiencies in processing proprioception. We evaluated the specific deficits of PD patients in sensorimotor integration and proprioceptive processing by testing their ability to perform three-dimensional (3D) reaching movements in four conditions in which the sensory signals defining target and hand positions (visual and/or proprioceptive) varied. Ten healthy subjects and 11 PD patients, ON dopamine medication and in the OFF state, were tested. PD patients in the OFF state showed a greater mean level of 3D errors relative to controls when the only available sensory information about target and hand position came from proprioception, but this difference did not reach significance. This indicates that deficient proprioception is not an early key feature of PD. Interestingly, the inaccuracies of a number of PD subjects further increased in the ON medicated state relative to healthy controls when reaching to proprioceptively-defined targets, and this between group difference was statistically significant. However, dopamine medication did not consistently degrade the reaching accuracy of PD patients, with both negative and positive effects on accuracy of reaching to proprioceptive-defined targets. Together, these findings indicate that dopamine replacement therapy not only did not normalize sensorimotor performance to the level of controls, but also induced deficits in the processing of proprioceptive information in some of the PD patients tested. Furthermore, the diversity of effects of medication on accuracy of reaching to proprioceptively-defined targets supports the idea that dysfunction of dopaminergic circuits within the basal ganglia is not primarily responsible for the proprioceptive processing deficits of PD patients.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Mongeon, D" sort="Mongeon, D" uniqKey="Mongeon D" first="D." last="Mongeon">D. Mongeon</name>
</noRegion>
<name sortKey="Blanchet, P" sort="Blanchet, P" uniqKey="Blanchet P" first="P." last="Blanchet">P. Blanchet</name>
<name sortKey="Blanchet, P" sort="Blanchet, P" uniqKey="Blanchet P" first="P." last="Blanchet">P. Blanchet</name>
<name sortKey="Messier, J" sort="Messier, J" uniqKey="Messier J" first="J." last="Messier">J. Messier</name>
<name sortKey="Messier, J" sort="Messier, J" uniqKey="Messier J" first="J." last="Messier">J. Messier</name>
<name sortKey="Mongeon, D" sort="Mongeon, D" uniqKey="Mongeon D" first="D." last="Mongeon">D. Mongeon</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002096 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002096 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:09-0119781
   |texte=   IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022